Dengue
Conditions
Interventions
Intervention type:DRUG
Name of intervention:Sumilarv2MR
Dose form / Japanese Medical Device Nomenclature:OTHER
insect growth regulator
Route of administration / Site of application:NOT APPLICABLE
Dose
Sponsors
Sumitomo Chemical Company Co. Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: elementary and junior high school students living in intervention and control areas
Exclusion criteria
Exclusion criteria: Children under 5 years old and adults over 15 years old
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The ratio of positive IgG antibody in intervention and control | — |
Secondary
| Measure | Time frame |
|---|---|
| The number of dengue patients visited the central hospital in Tuy Hoa city | — |
Countries
Vietnam
Contacts
Public ContactTakashi Tsunoda
Nagasaki University, Institute of Tropical Medicine
Outcome results
None listed